Bayer stock at EUR 44.38 ahead of Xetra open: health group little changed
Published on 10/19/2026 at 08:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTrading setup and operations
- Bayer’s business spans pharmaceuticals, crop science and consumer health.
- The investor-relations page highlights third-quarter 2026 results.
- Bayer stock trades pre-market at EUR 44.38 at 8:21 a.m. CEST at Lang & Schwarz on October 19, 2026, little changed versus the Xetra close of October 16, 2026.
Bayer earns revenue through pharmaceuticals, crop-science products and consumer-health goods serving health and nutrition needs, according to the company’s Investor Relations materials. Bayer stock trades pre-market at EUR 44.38 at 8:21 a.m. CEST at Lang & Schwarz on October 19, 2026, little changed versus the Xetra close of October 16, 2026 (EUR 44.46).
Ahead of the Xetra open
The stock is EUR 0.08 below the Xetra close of October 16, 2026. The bid is EUR 44.35 and the ask is EUR 44.41. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Bayer stock.
Business and reporting focus
The Bayer Investor Relations page identifies pharmaceuticals, Crop Science and Consumer Health as the group’s core business areas. It highlights third-quarter 2026 results and says Bayer publishes quarterly communications for the first and third quarters as well as half-year financial reports. Market context: Market report DAX.
